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Abstract: Recently, the interplay between autophagy and apoptosis has become an important factor in
chemotherapy for cancer treatment. Inhibition of autophagy may be an effective strategy to improve
the treatment of chemo-resistant cancer by consistent exposure to chemotherapeutic drugs. However,
no reports have clearly elucidated the underlying mechanisms. Therefore, in this study, we assessed
whether salinomycin, a promising anticancer drug, induces apoptosis and elucidated potential
antitumor mechanisms in chemo-resistant prostate cancer cells. Cell viability assay, Western blot,
annexin V/propidium iodide assay, acridine orange (AO) staining, caspase-3 activity assay, reactive
oxygen species (ROS) production, and mitochondrial membrane potential were assayed. Our data
showed that salinomycin alters the sensitivity of prostate cancer cells to autophagy. Pretreatment
with 3-methyladenine (3-MA), an autophagy inhibitor, enhanced the salinomycin-induced apoptosis.
Notably, salinomycin decreased phosphorylated of AKT and phosphorylated mammalian target of
rapamycin (mTOR) in prostate cancer cells. Pretreatment with LY294002, an autophagy and PI3K
inhibitor, enhanced the salinomycin-induced apoptosis by decreasing the AKT and mTOR activities
and suppressing autophagy. However, pretreatment with PD98059 and SB203580, an extracellular
signal-regulated kinases (ERK), and p38 inhibitors, suppressed the salinomycin-induced autophagy
by reversing the upregulation of ERK and p38. In addition, pretreatment with N-acetyl-L-cysteine
(NAC), an antioxidant, inhibited salinomycin-induced autophagy by suppressing ROS production.
Our results suggested that salinomycin induces apoptosis, which was related to ROS-mediated
autophagy through regulation of the PI3K/AKT/mTOR and ERK/p38 MAPK signaling pathways.
Keywords: salinomycin; reactive oxygen species; apoptosis; autophagy; prostate cancer cells
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1. Introduction
Prostate cancer is the most frequently diagnosed and the most fatal type of cancer in men [1].
Recently, prostate cancer incidence and mortality rates have rapidly increased in most Asian countries,
including Korea and Japan [2]. Many investigators have attempted to identify the underlying
mechanisms of these cancers, but these are still unknown. Recently, several new therapies have
been tested against prostate cancer, including vaccines, monoclonal antibodies, and other types of
targeted drugs [3]. Importantly, new drugs and combination therapies have been used to target
chemo-resistant and advanced metastatic prostate cancer [4].
Autophagy is a new target mechanism for chemo-resistant cancer therapy [5]. Autophagy is
a catabolic mechanism that involves degradation of unnecessary or dysfunctional components [6].
This process enables cells to cope with various stresses, such as nutrient deprivation, endoplasmic
reticulum (ER) stress, pathogen infection, or hypoxia, which is considered a survival mechanism [7].
However, during harsh or the prolonged stress or in apoptosis-deficient cells, autophagy can participate
in cell death [8]. More recently, it was reported that reactive oxygen species (ROS) are key molecules in
crosstalk between apoptosis and autophagy [9,10]. ROS regulate cell survival and growth, but excessive
ROS lead to irreversible cellular damage, such as autophagy and/or apoptosis induction in several
types of cancer cells [11]. Additionally, these two processes share many pathways commonly used in
the response to diverse stressors. For example, ROS overproduction as well as phosphatidylinositol
3-kinase/Akt (a serine/threonine kinase also known as protein kinase B (PKB))/mammalian target of
rapamycin (PI3K/AKT/mTOR) inactivation and mitogen-activated protein kinase (MAPK) activation
have been reported in both apoptosis and autophagy [12,13].
Salinomycin is a monocarboxylic ionophore isolated from Streptomyces albus [14]. It has been
used to transport cations across biological membranes as a novel class of anti-cancer agents [15,16].
We previously reported that salinomycin induces apoptosis via cell cycle arrest and ROS-mediated
mitochondrial pathways in prostate cancer cells [9,17]. Additionally, we demonstrated that this
drug enhanced cytotoxicity by decreasing the efflux of doxorubicin in multidrug-resistant breast
cancer cells [18]. More recently, salinomycin was shown to induce autophagy with concomitant ROS
production or ER stress in human cancer cells [19].
The present study investigated the autophagy pathway as a protective factor of apoptosis in
chemo-resistant prostate cancer cells. With the aim of exploring the anticancer effects of salinomycin,
we examined the induction of apoptosis and autophagy by salinomycin in prostate cancer cells.
Our results demonstrated that salinomycin inhibits the viability of cells by modulating apoptosis and
autophagy. Inhibition of the autophagy pathway enhanced the salinomycin-induced apoptosis, which
confirmed the role of ROS in crosstalk between autophagy and apoptosis. Thus, autophagy inhibition
may be a therapeutic strategy to improve the treatment of chemo-resistant cancer.
2. Results
2.1. Salinomycin Induces Both Apoptosis and Autphagy in Human Prostate Cancer Cells
Previously, we reported the cytotoxic effects of salinomycin on human prostate cancer cell lines
using MTT assays [9]. Additionally, we confirmed the salinomycin induced apoptosis in human
prostate cancer PC-3 cells. However, the resistance to salinomycin-induced apoptosis between the
PC-3 and LNCaP cells is unknown. Consistent with previous results, we confirmed that LNCaP cells
were more susceptible to salinomycin than PC-3 cells. Furthermore, non-malignant RWPE-1 cells
were relatively less sensitive to salinomycin, which did not significantly inhibit cell viability (data not
shown). The percentages of apoptotic cells were 67.09% and 34.75% at 2 µM salinomycin in LNCaP
and PC-3 cells, respectively. These results indicated that LNCaP cells were more sensitive to apoptosis
than PC-3 cells (Figure 1A).
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Figure 1. Salinomycin (Sal) induces both apoptosis and autophagy in human prostate cancer cells. (A) 
Apoptosis induction. Flow cytometric analysis of annexin‑V/propidium iodide (PI) staining; and (B) 
autophagy induction. Flow cytometric analysis of acridine orange (AO) staining. LNCaP and PC‑3 
cells were treated with 2 µM salinomycin for 48 h; (C,D) LC3 and Beclin‑1 expression; (C) LNCaP 
cells; and (D) PC‑3 cells. Cells were treated with 2 µM salinomycin for the indicated times. After 
treatment, total cell lysates were subjected to SDS‑PAGE for Western blot analysis; and (E) acidic 
vesicular detection. After treatment with 2 µM salinomycin for the indicated times, cells were stained 
with AO, and then cells were visualized using a laser scanning confocal microscope. Magnification, 
600×. All data were representative of at least three independent experiments. Data were shown as the 
mean ± SD. * p < 0.05. 
Next, to determine whether salinomycin decreases cell survival via induction of autophagy, we 
verified the autophagy markers in salinomycin‑treated prostate cancer cells using acridine orange 
(AO) staining. Salinomycin induced the accumulation of acidic vesicles (Figure 1B). Based on a 
comparison of the acidic vesicular rate, PC‑3 cells had a higher susceptibility to autophagy than that 
of LNCaP cells, which was the opposite of the apoptosis results (Figure 1B). Additionally, LC3‑I/II 
activated forms and Beclin‑1 expression levels were increased in PC‑3 cells compared to those of 
LNCaP cells in a time‑dependent manner (Figure 1C,D). The formation of acidic vesicular organelles 
was assessed using confocal microscopy, control cells displayed green fluorescence with minimal red 
fluorescence, while salinomycin‑treated LNCaP and PC‑3 cells showed an increase in red 
fluorescence (Figure 1E). Consequently, we hypothesized that the differences in salinomycin‑induced 
cytotoxicity between chemo‑sensitive LNCaP cells and chemo‑resistant PC‑3 cells were associated 
with the induction of autophagy. 
2.2. Autophagy Inhibition Enhances Salinomycin-Induced Apoptosis in Prostate Cancer Cells 
To further confirm the involvement of autophagy in salinomycin‑induced apoptosis, we 
evaluated the effects of 3‑methyladenine (3‑MA), an autophagy inhibitor. Salinomycin‑induced 
Figure 1. Salinomycin (Sal) induces both apoptosis and autophagy in human prostate cancer cells.
(A) Apoptosis induction. Flow cytometric analysis of annexin-V/propidium iodide (PI) staining;
and (B) autophagy induction. Flow cytometric analysis of acri in orange (AO) staining. LNCaP
and PC-3 cells were treated with 2 µM salinomycin for 48 h; (C,D) LC3 and Beclin-1 expression;
(C) LNCaP cells; nd (D) PC-3 c lls. Cells were treated with 2 µM salinomycin for the indic ted times.
After treatment, total cell lysates were subjected to SDS-PAGE for Western blot analysis; and (E) acidic
vesicular detection. After treatment with 2 µM salinomycin for the indicated times, cells were stained
with AO, and then cells were visualized using a laser scanning confocal microscope. Magnification,
600×. All data were representative of at least three independent experiments. Data were shown as the
mean ± SD. * p < 0.05.
Next, o determine whether salinomycin decreases cell survival via ind ction of utophagy, we
verified the autophagy markers in salinomycin-treate prostate cancer cells using acridine orange (AO)
staining. Salinomycin induced the accumulation of acidic vesicles (Figure 1B). Based on a comparison
of the acidic vesicular rate, PC-3 cells had a higher susceptibility to autophagy than that of LNCaP
cells, which was the opposite of the apoptosis results (Figure 1B). Additionally, LC3-I/II activated
forms and Beclin-1 expression levels were increased in PC-3 cells compared to those of LNCaP cells in
a time-dependent manner (Figure 1C,D). The formation of acidic vesicular organelles was assessed
using confocal microscopy, control cells displayed green fluorescence with minimal red fluorescence,
while salinomycin-treated LNCaP and PC-3 cells showed an increase in red fluorescence (Figure 1E).
Consequently, we hypothesized that the differences in salinomycin-induced cytotoxicity between
chemo-sensitive LNCaP cells and chemo-resistant PC-3 cells were associated with the induction
of autophagy.
2.2. Autophagy Inhibition Enhances Salinomycin-Induced Apoptosis in Prostate Cancer Cells
To further confirm the involvement of autophagy in salinomycin-induced apoptosis, we evaluated
the effects of 3-methyladenine (3-MA), an autophagy inhibitor. Salinomycin-induced autophagy
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was significantly inhibited by 3-MA in both PC-3 and LNCaP cells (Figure 2A). Furthermore,
salinomycin-induced apoptosis were enhanced by autophagy inhibition (Figure 2B). Additionally,
we confirmed by Western blot and confocal microscopy analysis that the appearance of punctate
LC-3B dots was inhibited in 3-MA pretreated cells (Figure 2C,D). Additionally, salinomycin-induced
caspase-3 activation and poly (ADP-ribose) polymerase (PARP) protein cleavage were enhanced by
autophagy inhibition (Figure 2E,F). Taken together, the results indicated that salinomycin-induced
autophagy protects against apoptosis in prostate cancer cells and inhibition of autophagy subsequently
enhances apoptosis through caspase activation in prostate cancer cells.
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Figure 2. Autophagy inhibition enhances salinomycin‑induced apoptosis in prostate cancer cells. (A) 
The effects of 3‑MA on salinomycin‑induced autophagy. Cells were pretreated with 1 mM 3‑MA for 
1 h, and acridine orange (AO) stained cells were evaluated by flow cytometry; (B) the effects of 3‑MA 
on salinomycin‑induced apoptosis. Cells were pretreated with 1 mM 3‑MA for 1 h, annexin‑V‑FITC 
stained cells were evaluated by flow cytometry; (C) the effects of 3‑MA on LC3, caspase‑3 and PARP 
protein expression. Cells were pretreated with 1 mM 3‑MA for 1 h, and the proteins were detected by 
Western blot analysis; (D) the effects of 3‑MA on immunofluorescence staining for LC3. Cells were 
pretreated with 1 mM 3‑MA for 1 h, and the fluorescence was detected by confocal microscopy. 
Magnification, 1800×; (E) the effects of 3‑MA on LC3, caspase‑3 and PARP protein expression. Cells 
were pretreated with 1 mM 3‑MA for 1 h, and the proteins were detected by western blot analysis; 
and (F) the effect of 3‑MA on caspase‑3 activity. Cells were pretreated with 1 mM 3‑MA for 1 h, and 
the proteins were detected by a caspase‑3 colorimetric assay kit. All data were representative of at 
least three independent experiments. Data were shown as the mean ± SD. * p < 0.05. 
Figure 2. Autophagy inhibition enhances salinomycin-induced apoptosis in prostate cancer cells.
(A) The effects of 3-MA on salinomycin-induced autophagy. Cells were pretreated with 1 mM 3-MA for
1 h, and acridine orange (AO) stained cells were evaluated by flow cytometry; (B) the effects of 3-MA on
salinomycin-induced apoptosis. Cells were pretreated with 1 mM 3-MA for 1 h, annexin-V-FITC stained
cells were evaluated by flow cytometry; (C) the effects of 3-MA on LC3, caspase-3 and PARP protein
expression. Cells were pretreated with 1 mM 3-MA for 1 h, and the proteins were detected by Western
blot analysis; (D) the effects of 3-MA on immunofluorescence staining for LC3. Cells were pretreated
with 1 mM 3-MA for 1 h, and the fluorescence was detected by confocal microscopy. Magnification,
1800×; (E) the effects of 3-MA on LC3, caspase-3 and PARP protein expression. Cells were pretreated
with 1 mM 3-MA for 1 h, and the proteins were detected by western blot analysis; and (F) the effect
of 3-MA on caspase-3 activity. Cells were pretreated with 1 mM 3-MA for 1 h, and the proteins were
detected by a caspase-3 colorimetric assay kit. All data were representative of at least three independent
experiments. Data were shown as the mean ± SD. * p < 0.05.
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2.3. The PI3K/AKT/mTOR Pathway Is Involved in the Regulation of Both Salinomycin-Induced Autophagy
and Apoptosis in Prostate Cancer Cells
To ascertain the possible role of PI3K/AKT/mTOR pathways in salinomycin-induced cell death,
we verified the expression levels of the phosphorylated forms of AKT and mTOR. The expression
of phosphorylated AKT was decreased in a time-dependent manner in both PC-3 and LNCaP cells
(Figure 3A,B). Furthermore, mTOR, an important downstream executor of AKT, showed decreased
phosphorylation (Figure 3A,B). Next, we determined the effects of the PI3K/AKT pathway using
AO staining. Salinomycin-induced autophagy was recovered by LY294002, a PI3K/AKT inhibitor
in both PC-3 and LNCaP cells (Figure 3C). Additionally, protein expression of the autophagy
marker LC-3 was rescued (Figure 3E). Furthermore, the inhibition of autophagy by LY294002
enhanced salinomycin-induced apoptosis (Figure 3D), which was associated with caspase-3 activation
(Figure 3E,F) and PARP cleavage (Figure 3E). Inhibition of autophagy by 3-MA treatment enhanced
inactivation of PI3/AKT/mTOR (data not shown). These data showed that inhibition of autophagy
by LY294002 and 3-MA enhanced salinomycin-induced apoptosis. Therefore, the PI3K/AKT/mTOR
pathway is involved in the regulation of both autophagy and apoptosis induced by salinomycin.
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Figure 3. The PI3K/AKT/mTOR pathway is involved in the regulation of both salinomycin-induced
autophagy and apoptosis in prostate cancer cells. (A,B) AKT/mTOR expression. (A) PC-3 cells.
(B) LNCaP cells. Cells were treated with 2 µM salinomycin for the indicated times. After treatment,
total cell lysates were subjected to SDS-PAGE for Western blot analysis; (C) the effects of LY294002
on salinomycin-induced autophagy. Cells were pretreated with 10 µM LY294002 for 1 h, and
acridine orange (AO) stained cells were evaluated by flow cytometry; (D) the effects of LY294002
on salinomycin-induc d apoptosis. Cells were pretreated with 10 µM LY294002 for 1 h, and
annexin-V-FITC stained cells were evaluated by flow cytometry; (E) the Effects of LY294002 on LC3,
procaspase-3 and PARP protein expressio . Cells were pr treated with 10 µM LY294002 for 1 h, and
then the proteins were detected by Western blot analysis; and (F) the effect of LY294002 on caspase-3
activity. PC-3 cells were pretreated with 10 µM LY294002 for 1 h, and the proteins were detected
by a caspase-3 colorimetric assay kit. All data were representative of at least three independent
experiments. Data were shown as the mean ± SD. * p < 0.05.
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2.4. The ERK and p38 MAPK Pathways Are Involved in the Regulation of Salinomycin-Induced Autophagy in
Prostate Cancer Cells
Several reports have been shown that MAPK signaling pathways are involved in the regulation
of autophagy [12]. We found that salinomycin activated extracellular signal-regulated kinases (ERK)
and p38 MAPK in a time-dependent manner in both PC-3 and LNCaP cells (Figure 4A,B). However,
JNK expression was not changed (data not shown). To further confirm whether regulation of the
MAPK pathway affects salinomycin-induced autophagy in prostate cancer cells, we used AO staining
and Western blot analysis. Both PD98059, an ERK inhibitor, and SB203580, a p38 inhibitor, decreased
salinomycin-induced autophagy in both PC-3 and LNCaP cells (Figure 4C,D). Additionally, protein
expression of the autophagy marker LC3 was recovered (data not shown). These results showed
that ERK and p38 MAPK activation are closely linked to salinomycin-induced autophagy in prostate
cancer cells.
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that ROS are key molecules in apoptosis and autophagy [11]. We assessed whether ROS production 
is associated with salinomycin‑induced autophagy of prostate cancer cells. Salinomycin‑induced 
autophagy was recovered by N‑acetyl‑L‑cysteine (NAC), a ROS scavenger in both PC‑3 and LNCaP 
cells (Figure 5A). Consistent with AO staining results, salinomycin‑induced LC3 conversion was 
inhibited by NAC in prostate cancer cells (Figure 5B). Next, to determine whether inhibition of 
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Figure 4. The ERK and p38 MAPK pathways are involved in the regulation of salinomycin-induced
autophagy in prostate cancer cells. (A,B) ERK and p38 MAPK protein expression. (A) PC-3 cells.
(B) LNCaP cells. Cells were treated with 2 µM salinomycin for the indicated times. After treatment,
total cell lysates were subjected to SDS-PAGE for Western blot analysis; (C) the effect of PD98059
on salinomycin-induced autophagy; (D) the effect of SB203580 on salinomycin-induced autophagy.
Cells were pretreated with 10 µM PD98059 or 10 µM SB203580 for 1 h, and acridine orange (AO) stained
cells were evaluated by flow cytometry. All data were representative of at least three independent
experiments. Data were shown as the mean ± SD. * p < 0.05.
2.5. Autophagy Inhibition Stimulates ROS Production in Prostate Cancer Cells
Previously, we reported that salinomycin induces apoptosis via accumulation of reactive oxygen
species (ROS) and the mitochondrial pathway in PC-3 cells [9]. Several recent reports have shown
that ROS are key molecules in apoptosis and autophagy [11]. We assessed whether ROS production
is ss ciated with salinomycin-induced autophagy of prostate cancer cells. Salinomycin-induced
autophagy was recovered by N-acetyl-L-cysteine (NAC), ROS s avenger in both PC-3 and LNCaP
cells (Figure 5A). o sistent with AO stainin results, salinomycin-induced LC3 conversion was
inhibited b NAC in prostate cancer cells (Figure 5B). Next, to determine whether inhibition of
autophagy timulates ROS productio , we analyzed the cells for ROS production b flow cytometry.
ROS levels showed greater increases in the cells treated ith a combination of salinomycin and
3-MA than that of salinomycin alone (Figure 5C,D). This increase was efficiently recovered when the
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cells were pretreated with NAC in both PC-3 and LNCaP cells (Figure 5C,D). Finally, the increase in
salinomycin-induced apoptosis by 3-MA was completely prevented by the inhibition of ROS-mediated
autophagy by NAC (Figure 5E,F). Furthermore, we assessed the effects of ROS production between
the PI3K/AKT/mTOR and MAPK pathways. The results showed that the combination treatment with
salinomycin and NAC increased AKT and mTOR phosphorylation compared with that of salinomycin
treatment alone (Supplementary Figure S1A). ERK and p38 MAPK were decreased by the combination
treatment with salinomycin and NAC (Supplementary Figure S1B). These results showed that ROS
production plays a key role in both apoptosis and autophagy. In addition, ROS production is upstream
of the PI3K/AKT/mTOR and MAPK pathways in salinomycin-induced autophagy.
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3. Discussion
Salinomycin is an ionophore isolated from Streptomyces albus, which has been used as a monocarboxylic
polyether antibiotic [14]. Many reports have shown that salinomycin has potent anticancer activity
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through the induction of apoptosis, which is dependent on various molecular mechanisms, such as
upregulation of p21, downregulation of survivin, calpain, and cytochrome c-mediated cell death in
many cancer cell lines [17,20]. Additionally, salinomycin markedly inhibited cell growth in a variety of
cancer cells, including drug-sensitive cells and -resistant cancer cells [18,21]. Previous reports showed
that salinomycin induced ROS-mediated apoptosis via mitochondrial dysfunction in PC-3 cells [9].
Here, we demonstrated that salinomycin induces ROS-mediated apoptosis in prostate cancer cells,
accompanied by an increase in autophagy for cancer cell survival.
Interestingly, salinomycin has different effects of apoptosis depending on the cell type. In this
study, we showed that the apoptotic rates of hormone-independent and chemo-resistant PC-3 cells
were much lower than those of the hormone-dependent and chemo-sensitive LNCaP cells (Figure 1).
These results suggested that other cytoprotective mechanisms are involved in apoptosis resistance, for
example, autophagy induction by salinomycin. Autophagy is one of the key mechanisms to remove
mis-folded or aggregated proteins and maintain energy homeostasis during the stress response [22,23].
Recently, autophagy has been widely studied in chemo-resistant cancer [24,25] and the regulators of
crosstalk between apoptosis and autophagy have also been examined [11,26]. In this study, salinomycin
induced autophagy by LC3 conversion in all of the cell lines. However, salinomycin-induced autophagy
rates in drug-sensitive LNCaP cells were lower than those in drug-resistant PC-3 cells (Figure 1).
Additionally, as expected, salinomycin-induced autophagy was inhibited by an autophagy inhibitor,
3-MA. Inhibition of autophagy enhanced salinomycin-induced apoptosis via caspase-3 activation in
both PC-3 and LNCaP cells (Figure 2). These results indicated that autophagy affects the resistance to
apoptosis in cancer cells.
Many reports have shown that the mechanisms linking apoptosis and autophagy are related
to ROS production [10,27]. Recent evidence has demonstrated crosstalk between autophagy and
apoptosis through several commonly molecules, such as p53, Bcl-2 families and PI3K/AKT/mTOR
signal pathways [12]. Additionally, the PI3K/AKT/mTOR pathway plays an important role in the
resistance to a number of anti-cancer agents [28]. Mitogen-activated protein kinase (MAPK) pathways
such as C-jun N-terminal kinase (JNK), p38 and extracellular signal-regulated kinases (ERK), are
involved in cell survival and resistance associated with autophagy and apoptosis in many cancer
cells following exposure to different stresses [29]. Additionally, it has been reported that ROS inhibits
PI3K/AKT/mTOR signaling [30] and induces MAPK signaling [31]. Furthermore, intracellular ROS
production has vital roles in PI3K/AKT/mTOR inactivation and MAPK activation during apoptosis
and autophagy [32]. In this study, autophagy and LC3 expression were significantly restored by
a ROS scavenger, NAC, in both PC-3 and LNCaP cells. In addition, inhibition of autophagy led to
an increase in ROS formation and the salinomycin-induced apoptosis in both PC-3 and LNCaP cells
(Figure 5). Moreover, the inactivation of AKT/mTOR by the PI3K/AKT inhibitor LY294002 enhanced
salinomycin-induced apoptosis (Figure 3). Inactivation of MAPK proteins ERK and p38 decreased
salinomycin-induced autophagy by the ERK inhibitor PD98059 or the p38 MAPK inhibitor SB203580,
respectively (Figure 4). Furthermore, inhibition of ROS generation linked to AKT/mTOR, ERK and p38
activation was restored in both PC-3 and LNCaP cells. These results implied that salinomycin-induced
autophagy is triggered the ROS-mediated PI3K/AKT/mTOR and MAPK pathways.
4. Materials and Methods
4.1. Reagents and Antibodies
Acridine orange (AO), 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA), 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI), N-acetyl-L-cysteine (NAC) and 3-methyladenine (3-MA) were
purchased from Sigma Chemical Co. (St. Louis, MO, USA). A FITC Annexin V Apoptosis Detection Kit
(BD Biosciences, San Jose, CA, USA) was obtained. A Caspase-3 colorimetric assay kit was obtained
from R&D Systems Inc. (Minneapolis, MN, USA). LY294002, PD98059 and SB203580 were purchased
from TOCRIS (Bristol, UK). The ECL Western Kit was purchased from Amersham (Arlington Heights,
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IL, USA). Antibodies against LC-3B, Beclin-1, β-actin, phosphor-AKT, total AKT, phosphor-ERK, total
ERK, phospho-p38, total p38, phosphor-JNK, and total JNK were purchased from Cell Signaling
Technology (Beverly, MS, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA). The goat
anti-mouse IgG and goat anti-rabbit secondary antibodies were purchased from Enzo Life Science
(Farmingdale, NY, USA). The FITC-conjugated anti-rabbit IgG secondary antibody was purchased
from BioFX Laboratories (Owings Mills, MD, USA).
4.2. Cell Lines and Cell Culture
The human prostate cancer cell lines PC-3 and LNCaP cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA, USA). These cells were maintained and cultured in DMEM
(WelGENE Inc., Daejeon, Korea) supplemented with 10% fetal bovine serum (FBS) (WelGENE Inc.),
100 units/mL of penicillin and 100 µg/mL of streptomycin (WelGENE Inc.) at 37 ◦C in a humidified
atmosphere with 5% CO2.
4.3. Annexin V/Propidium Iodide (PI) Assay
For detection of apoptotic cells, a FITC Annexin V Apoptosis Detection Kit was used. Briefly,
human prostate cancer PC-3 and LNCaP cells were cultured in 6-well plates at a density of 5 × 104/well.
After treatment with salinomycin, cells were harvested, and then mixed in 100 µL of 1× binding buffer
and stained with annexin-V/propidium iodide (PI) at room temperature for 15 min. The stained
cells were analyzed by flow cytometry (FACSCalibur, Becton Dickinson, Franklin Lakes, NJ, USA),
and the apoptotic cells were calculated using Cell Quest Pro software (version 5.1) on Mac® OS 9
(Becton Dickinson).
4.4. Detection of Acidic Vesicular Organelles
For analysis of the acidic vesicular organelles, human prostate cancer PC-3 and LNCaP cells
were cultured in a glass-bottom dish. After treatment with salinomycin for the indicated times,
cells were stained with 1 µM acridine orange at 37 ◦C in the dark for 20 min. Then cells were
washed with phosphate-buffered saline (PBS) and visualized using with a laser scanning confocal
microscope (Olympus FluoView FV1000, Tokyo, Japan). Additionally, to quantify the number of acidic
vesicles, cells were harvested and washed with PBS. Then, the cells were analyzed by flow cytometry
(FACSCalibur, Becton Dickinson) and calculated using Cell Quest Pro software (version 5.1) on Mac®
OS 9 (Becton Dickinson).
4.5. Immunofluorescence for LC-3
The LC-3 expression levels were determined using an immunofluorescence analysis.
Human prostate cancer PC-3 and LNCaP cells were seeded in a glass-bottom dish. After treatment with
salinomycin with or without 1 mM 3-MA for 48 h, the cells were fixed with 3% (v/v) paraformaldehyde
for 10 min. After fixation, the cells were permeabilized with 0.5% (v/v) Triton X-100 for 10 min and
blocked with 3% (w/v) bovine serum albumin (BSA) for 2 h at room temperature. After blocking, the
cells were incubated with primary LC-3 antibody (1:400 diluted in BSA buffer) at room temperature
for 2 h and then reacted with FITC-conjugated anti-rabbit IgG secondary antibody. DAPI was used
to stain the nuclei. Samples were visualized with a laser scanning confocal microscope (Olympus
FluoView FV1000).
4.6. Measurement of Intracellular ROS Generation
Intracellular ROS generation was measured using the DCF-DA fluorescent dye. Human
prostate cancer PC-3 and LNCaP cells were cultured in six-well plates at a density of 5 × 104/well.
After treatment with salinomycin, the cells were incubated with 10 µM DCF-DA at 37 ◦C for 30 min.
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Cells were washed twice with PBS and analyzed with flow cytometry (FACSCalibur, Becton Dickinson)
and Cell Quest Pro software (version 5.1) on Mac® OS 9 (Becton Dickinson).
4.7. Western Blot Analysis
Cell extracts were prepared by incubating the cells in lysis buffer (150 mM NaCl, 10 mM Tris
(pH 7.4), 5 mM EDTA (pH 8.0), 1% Triton X-100, 1 mM PMSF, 20 µg/mL aprotinin, 50 µg/mL
leupeptin, 1 mM benzidine, 1 mg/mL pepstatin, 8 mM sodium pyrophosphate, and 20 mM
β-glycerophosphate). Forty micrograms of proteins were electrophoretically separated using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with an 8–15% gel and transferred to
a polyvinylidenefluoride (PVDF) membrane. After blocking with TBS-T buffer (20 mM Tris (pH 7.4),
150 mM NaCl, and 0.1% Tween 20) containing 5% skim milk, membranes were incubated with primary
and secondary antibodies. The membranes were then washed with TBS-T buffer and visualized
with ECL Western blot analysis detection reagents. The density of each band was determined with
a fluorescence scanner (LAS 3000, Fuji Film, Tokyo, Japan) and analyzed with Multi Gauge V3.0
software (Fuji Film).
4.8. Measurement of Caspase-3 Activity
For detection of caspase-3 activation, a caspase-3 colorimetric assay kit (R&D Systems Inc.) was
used according to the manufacturer’s protocol. Equal amounts of protein (220 µg) were resuspended
in reaction buffer containing substrate (Ac-DEVD-pNA) and then incubated at 37 ◦C for 4 h in the
dark. The absorbance of the released pNA was measured at 405 nm using an ELISA reader.
4.9. Statistical Analysis
Experiments were repeated at least three times with consistent results. Unless otherwise stated,
data were expressed as the mean ± SD. ANOVA was used to compare the experimental groups to the
control values, whereas comparisons between multiple groups were performed using Tukey’s multiple
comparison test. The results were statistically significant at * p < 0.05.
5. Conclusions
In conclusion, salinomycin markedly inhibited the cell growth in not only drug-sensitive cells,
but also drug-resistant cells. Above all, salinomycin has different effects on apoptosis depending on
the cell type. Additionally, ROS play a critical role in salinomycin-induced autophagy regulated
via ROS-mediated PI3K/AKT/mTOR and ERK/p38 MAPK pathways in prostate cancer cells.
Furthermore, the enhancement of apoptosis induced by ROS-mediated autophagy inhibition suggested
that cross talk between apoptosis and autophagy functions as a resistance mechanism against apoptosis.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/5/1088/s1.
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ERK Extracellular signal-regulated kinases
JNK c-Jun N-terminal kinase
MAPK Mitogen-activated protein kinases
MTT 3-(4,5-Dimethyl-thiazol-2-yl)-2,5-diphenyl-etrazolium bromide
NAC N-acetyl-L-cystein
PARP Poly (ADP-ribose) polymerase
PI Propidium iodide
PVDF Polyvinylidenefluoride
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